Brain Metastases NewsLatest News On Brain Metastases ASCO 2025 Recap: Melanoma Highlights on TILs, Toxicity, and Diet-Driven Outcomes7/24/2025 10:00 AM Melanoma Updates From ASCO 2025 Focus on Resistance and Refinement7/3/2025 12:46 PM Taletrectinib Approved for NSCLC6/11/2025 5:43 PM Tiragolumab/Atezolizumab Shows No Significant Benefit in PD-L1–High NSCLC5/5/2025 4:59 AM Understanding Biomarkers in Early-Stage Melanoma2/24/2025 11:09 AM How New Research Is Redefining Melanoma Treatment1/22/2025 11:17 PM T-DXd Preserves Quality of Life and Cognitive Function in HER2-Positive Breast Cancer Patients12/20/2024 2:06 AM Synergy of Combination Therapy for NSCLC Brain Metastases?11/6/2024 7:36 AM Combining Radiotherapy With a TKI Extends Survival in NSCLC10/30/2024 8:05 AM Full Cognitive Recovery After Brain Radiotherapy Possible for Many Patients10/3/2024 9:24 AM